TAKNYSEPharmaceutical PreparationsAlso trades as TKPHF
TAKEDA PHARMACEUTICAL CO LTD
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 17, 2026
$19.61−0.06 (-0.31%)
Close on Oct 19, 2026
Takeda Pharmaceutical statistics
Financials through Mar 31, 2026, price-based ratios appear once a share price is available
Valuation
Market Cap
¥10.70T
Enterprise Value
¥14.99T
PS Ratio
2.37
PB Ratio
1.44
P/FCF Ratio
12.36
P/OCF Ratio
10.28
Enterprise value
EV / Sales
3.33
EV / EBITDA
20.61
EV / EBIT
2410.95
EV / FCF
17.32
Income (trailing twelve months)
Revenue
¥4.51T
Gross Profit
¥2.93T
Operating Income
¥6.22B
Pretax Income
-¥142.36B
Net Income
-¥152.39B
EBITDA
¥727.34B
EPS (Diluted)
-96.75 JPY
Margins
Gross Margin
65.1%
Operating Margin
0.14%
Pretax Margin
-3.16%
Profit Margin
-3.38%
EBITDA Margin
16.1%
FCF Margin
19.2%
Returns
Return on Equity (ROE)
-2.12%
Return on Assets (ROA)
-1.02%
Return on Invested Capital (ROIC)
0.04%
Return on Capital Employed (ROCE)
0.05%
Growth
Revenue Growth (YoY)
-1.66%
Net Income Growth (YoY)
-241.2%
EPS Growth (YoY)
-243.9%
FCF Growth (YoY)
1.06%
Revenue Growth (3Y CAGR)
3.81%
Revenue Growth (5Y CAGR)
7.10%
Balance sheet
Cash & Short-Term Investments
¥595.05B
Total Debt
¥4.88T
Net Cash (Debt)
-¥4.29T
Net Cash Per Share
-2487.76 JPY
Equity (Book Value)
¥7.43T
Book Value Per Share
4311.55 JPY
Tangible Book Value
-¥1.80T
Working Capital
¥258.43B
Financial position
Current Ratio
1.09
Quick Ratio
0.51
Debt / Equity
0.66
Debt / EBITDA
6.71
Debt / FCF
5.64
Net Debt / EBITDA
5.89
Interest Coverage
0.02
Cash flow (trailing twelve months)
Operating Cash Flow
¥1.04T
Capital Expenditures
-¥176.00B
Free Cash Flow
¥865.43B
FCF Per Share
502.24 JPY
Efficiency
Asset Turnover
0.30
Inventory Turnover
1.20
Revenue Per Employee
¥95.87M
Profits Per Employee
-¥3.24M
Employee Count
47,000
Dividends and yields
Earnings Yield
-1.42%
FCF Yield
8.09%
Buyback Yield
0.48%
Shareholder Yield
0.48%
FCF Payout Ratio
36.0%
Shares
Shares Outstanding
1,723,150,000
Shares Change (YoY)
-1.89%
Float
1,719,350,000
Shares Held by Insiders
0.22%
Shares Held by Institutions
6.05%
Taxes
Income Tax
¥9.77B
Scores
Altman Z-Score
1.17
Piotroski F-Score
5
Calculated by StockData from Takeda Pharmaceutical's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.